Clearance Summary
BAYER ADVIA CENTAUR CA 19-9 ASSAY received FDA 510(k) clearance under submission number K031393, sponsored by Bayer Healthcare, LLC. The device was reviewed via the Traditional premarket notification pathway and assigned to the Immunology review panel. The statutory decision date of record is 2003-06-24.
- Submission: K031393
- Applicant / Sponsor: Bayer Healthcare, LLC
- Clearance pathway: Traditional
- Review panel: Immunology
- Device class: Class II
- Regulation citation: 21 CFR 866.6010
- Decision date: 2003-06-24
Classification & Regulation
This clearance is catalogued under FDA product code NIG and 21 CFR 866.6010, within the Immunology review panel as a Class II device.